Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer

Several (pre-) clinical trials are currently investigating the benefit of HER2-targeted therapy in urothelial bladder cancer (UBC). Patients with HER2 amplified UBC could potentially profit from these therapies. However, little is known about histomorphology, HER2 protein expression patterns and occ...

Descripción completa

Detalles Bibliográficos
Autores principales: Tschui, J., Vassella, E., Bandi, N., Baumgartner, U., Genitsch, V., Rotzer, D., Seiler, R., Thalmann, G. N., Fleischmann, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460277/
https://www.ncbi.nlm.nih.gov/pubmed/25809292
http://dx.doi.org/10.1007/s00428-015-1729-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460277/
https://www.ncbi.nlm.nih.gov/pubmed/25809292
http://dx.doi.org/10.1007/s00428-015-1729-4

Ejemplares similares